40S ribosomal protein S30

40S ribosomal protein S30 is a protein that in humans is encoded by the FAU gene. This protein is a component of the 40S subunit of the ribosome, which is involved in the initiation of protein synthesis. The 40S ribosomal protein S30 is not just a structural component but also plays a role in the functional aspects of the ribosome, particularly in the translation process of mRNA into protein.
Function[edit]
The 40S ribosomal protein S30, as part of the 40S subunit, is crucial for the initiation phase of protein synthesis. It helps in the binding of mRNA and tRNA to the ribosome, facilitating the correct positioning of the mRNA for the translation process. This protein, along with other ribosomal proteins, contributes to the accuracy and efficiency of protein synthesis. The FAU gene that encodes for this protein also has implications in the regulation of apoptosis and cell cycle, indicating a broader role beyond its structural presence in the ribosome.
Gene[edit]
The FAU gene, located on human chromosome 20, encodes the 40S ribosomal protein S30. This gene is highly conserved across different species, highlighting its essential role in the ribosomal function and protein synthesis. Mutations in the FAU gene have been studied for their potential links to various diseases, although direct associations are still under research.
Clinical Significance[edit]
While direct clinical implications of mutations in the FAU gene are still being explored, the role of ribosomal proteins in diseases is increasingly recognized. Alterations in ribosomal proteins, including the 40S ribosomal protein S30, can affect ribosome biogenesis and function, potentially leading to diseases such as ribosomopathies, which are disorders caused by abnormalities in ribosome function. Understanding the specific functions and interactions of ribosomal proteins like S30 can aid in the development of therapeutic strategies for these conditions.
See Also[edit]

This article is a biochemistry stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian